Datasets:

jarrydmartinx
/

support2

Modalities:

Formats:

Size:

Libraries:

Dataset card Data Studio Files Files and versions Community

Dataset Viewer

Auto-converted to Parquet

Split (1)

train · 9.11k rows

age float64 18 102	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07	event_times int64 3 2.03k	event_indicators int64 0 1
62.84998	male	0	5	Lung Cancer	Cancer	0	11	$11-$25k	0	9,715	null	null	7	other	33.898438	20	0.262939	0.036995	1	0	0	metastatic	0.5	0.25	no dnr	5	97	6	69	22	36	388	1.799805	0.199982	1.199951	141	7.459961	null	null	null	7	7	null	7	2,029	0
60.33899	female	1	4	Cirrhosis	COPD/CHF/Cirrhosis	2	12	$11-$25k	44	34,496	null	null	29	white	52.695313	74	0.001	0	3	0	0	no	0	0	null	null	43	17.097656	112	34	34.59375	98	null	null	5.5	132	7.25	null	null	null	null	1	<2 mo. follow-up	1	4	1
52.74698	female	0	17	Cirrhosis	COPD/CHF/Cirrhosis	2	12	under $11k	0	41,094	null	null	13	white	20.5	45	0.790894	0.664917	4	0	0	no	0.75	0.5	no dnr	17	70	8.5	88	28	37.39844	231.65625	null	2.199707	2	134	7.459961	null	null	null	1	0	<2 mo. follow-up	0	47	1
42.38498	female	0	3	Lung Cancer	Cancer	2	11	under $11k	0	3,075	null	null	7	white	20.097656	19	0.698975	0.411987	1	0	0	metastatic	0.9	0.5	no dnr	3	75	9.099609	88	32	35	null	null	null	0.799927	139	null	null	null	null	0	0	no(M2 and SIP pres)	0	133	1
79.88495	female	0	16	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	26	50,127	null	null	18.666656	white	23.5	30	0.634888	0.532959	3	0	0	no	0.9	0.9	no dnr	16	59	13.5	112	20	37.89844	173.3125	null	null	0.799927	143	7.509766	null	null	null	null	2	no(M2 and SIP pres)	2	2,029	0
93.01599	male	1	4	Coma	Coma	1	14	null	55	6,884	null	null	5	white	19.398438	27	0.284973	0.214996	1	0	0	no	0	0	no dnr	4	110	10.398438	101	44	38.39844	266.625	null	null	0.699951	140	7.65918	null	null	null	null	1	<2 mo. follow-up	1	4	1
62.37097	male	0	9	CHF	COPD/CHF/Cirrhosis	1	14	$25-$50k	0	30,460	null	null	8	white	17.296875	46	0.892944	0.820923	1	0	0	no	null	0.7	no dnr	9	78	11.699219	120	28	37.39844	309.5	4.799805	0.399963	1.599854	132	7.479492	null	null	null	0	1	no(M2 and SIP pres)	1	659	1
86.83899	male	0	7	CHF	COPD/CHF/Cirrhosis	3	null	null	26	30,460	null	null	6.5	white	21.597656	53	0.670898	0.498962	1	1	0	no	0.8	0.4	no dnr	7	72	13.599609	100	26	37.59375	404.75	null	null	2	139	7.509766	null	null	null	null	0	null	0	142	1
85.65594	male	0	12	Lung Cancer	Cancer	2	12	null	26	null	null	null	8.5	black	15.898438	17	0.570923	0.248993	1	0	1	metastatic	0.05	0.000125	dnr after sadm	2	97	9.699219	56	20	36.59375	357.125	null	0.399963	1	143	7.449219	null	null	null	null	7	null	7	63	1
42.25897	female	0	8	Colon Cancer	Cancer	0	11	$25-$50k	0	9,914	null	null	8	hispanic	2.299805	9	0.952881	0.887939	1	0	0	metastatic	null	null	no dnr	8	84	11.298828	94	20	38.19531	null	4.699219	0.199982	0.799927	139	null	null	null	null	0	null	null	0.4948	370	1
47.94498	male	0	7	CHF	COPD/CHF/Cirrhosis	1	12	null	0	15,558	null	null	12.5	white	14.599609	14	0.935913	0.890991	1	0	0	no	0.7	0.5	no dnr	7	70	10.898438	105	24	36.5	null	4.199219	0.5	1	134	null	null	null	null	2	1	no(M2 and SIP pres)	1	114	1
59.20099	male	1	13	Lung Cancer	Cancer	0	14	null	0	29,388	null	null	8	white	16.398438	17	0.731934	0.461975	1	0	0	metastatic	null	null	dnr after sadm	12	77	10.798828	90	22	36.39844	null	null	null	1.099854	136	null	null	null	null	1	1	<2 mo. follow-up	1	13	1
29.002	female	0	4	Cirrhosis	COPD/CHF/Cirrhosis	1	16	$11-$25k	0	4,353	null	null	8	white	26.898438	30	0.850952	0.754883	1	0	0	no	null	null	no dnr	4	56	5.5	56	20	37.19531	null	2.899902	6.099609	0.699951	130	null	null	null	null	0	0	no(M2 and SIP pres)	0	160	1
68.14197	male	0	8	CHF	COPD/CHF/Cirrhosis	0	12	$11-$25k	0	19,783	null	null	16	white	20.296875	34	0.849976	0.75293	1	0	0	no	0.9	0.7	no dnr	8	68	9.398438	80	22	36	null	null	0.599976	2.599609	139	null	null	null	null	0	0	no(M2 and SIP pres)	0	1,866	1
43.53998	female	0	115	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	26	706,577	390,460.5	null	38.25	white	30.5	39	0.590942	0.481995	148	0	0	no	0.9	0.9	no dnr	115	67	24.597656	172	20	38.79688	113.32812	null	null	0.599976	134	7.399414	null	null	null	null	null	SIP>=30	2.76416	2,022	0
58.823	female	0	7	Lung Cancer	Cancer	1	12	>$50k	0	10,758	null	null	10	white	7.799805	11	0.856934	0.682983	1	0	0	metastatic	0.9	0.7	no dnr	7	97	15.898438	92	20	37.19531	null	4.299805	0.199982	0.799927	134	null	null	null	null	2	0	null	0	503	1
45.418	male	0	7	Lung Cancer	Cancer	2	null	null	0	8,400	null	null	7	white	16	4	0.768921	0.521973	1	0	0	metastatic	null	null	no dnr	7	97	10.798828	100	24	37.29688	585.125	null	0.299988	1.099854	137	7.489258	null	null	null	null	null	null	3.351563	827	1
63.66299	female	1	14	ARF/MOSF w/Sepsis	ARF/MOSF	0	22	$25-$50k	26	283,303	156,674.125	null	40	white	40.296875	58	0.212982	0.116989	13	0	0	no	0.1	0.001	dnr after sadm	12	69	30.097656	108	22	36.69531	155.53125	2.899902	14	2.899902	130	7.449219	null	null	null	null	0	<2 mo. follow-up	0	14	1
31.84399	male	1	15	Cirrhosis	COPD/CHF/Cirrhosis	2	16	under $11k	0	27,985	17,528.4375	null	10	white	33.898438	42	0.73291	0.581909	1	0	0	no	null	null	dnr after sadm	12	83	5	100	24	37.39844	null	1.699951	12.798828	0.299988	122	null	null	null	null	7	7	<2 mo. follow-up	7	15	1
55.13797	male	0	10	CHF	COPD/CHF/Cirrhosis	1	8	$11-$25k	0	18,191	null	null	14.5	hispanic	17.699219	25	0.904907	0.840942	1	0	0	no	0.5	0.5	no dnr	10	78	null	72	20	36	null	null	null	1.5	134	null	null	null	null	3	null	no(M2 and SIP pres)	2.511099	179	1
68.25494	male	0	7	Lung Cancer	Cancer	0	13	>$50k	0	10,755	null	null	8	white	5.599609	16	0.868896	0.704956	1	0	0	metastatic	0.9	0.7	no dnr	7	91	5	92	20	36.5	null	4.299805	0.299988	1.199951	138	null	null	null	null	0	0	no(M2 and SIP pres)	0	227	1
48.70398	male	0	23	Lung Cancer	Cancer	0	16	null	0	55,384	33,002.5	null	9.666664	other	26.199219	35	0.535889	0.213989	1	0	0	metastatic	0.5	0.125	dnr after sadm	11	66	12.5	125	30	37	170	null	null	1	133	7.519531	null	null	null	null	null	<2 mo. follow-up	3.263672	30	1
49.61298	female	0	50	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	542,266	288,592.25	null	33.75	white	31.699219	42	0.650879	0.55188	29	0	0	no	0.6	0.5	no dnr	50	67	11	120	48	38.89844	200	2	4.099609	0.599976	130	7.399414	null	null	null	null	5	adl>=4 (>=5 if sur)	5	2,019	0
50.724	female	0	3	Lung Cancer	Cancer	0	12	$25-$50k	0	4,913	null	null	10	asian	14.199219	11	0.786987	0.552979	1	0	0	metastatic	1	1	no dnr	3	71	9.798828	88	24	37.39844	null	null	null	0.899902	141	null	null	null	null	null	null	no(M2 and SIP pres)	2.065918	817	1
29.36099	female	0	4	Colon Cancer	Cancer	0	17	$25-$50k	0	7,792	null	null	13	white	18.898438	10	0.853882	0.674927	1	0	0	metastatic	0.5	0.1	no dnr	4	96	10.599609	112	20	37	null	3.699707	1.399902	0.599976	137	null	null	null	null	null	null	no(M2 and SIP pres)	1.814941	399	1
53.84	male	0	7	COPD	COPD/CHF/Cirrhosis	1	null	under $11k	0	9,871	6,112.4609	null	8	white	14.199219	16	0.939941	0.897949	1	0	0	no	0.9	0.6	dnr after sadm	4	134	7.799805	106	22	37.89844	304.125	3.799805	0.5	0.799927	141	7.379883	null	null	null	5	4	no(M2 and SIP pres)	4	1,064	1
82.41498	female	1	5	Lung Cancer	Cancer	0	null	null	44	7,212	null	null	9	white	27.296875	33	0.169983	0.011999	1	0	0	metastatic	null	null	dnr before sadm	-1	75	6.799805	114	20	37.19531	null	3.099609	null	1.799805	131	null	null	null	null	null	null	<2 mo. follow-up	3.704102	5	1
27.32399	male	1	7	MOSF w/Malig	ARF/MOSF	1	19	null	26	160,060	82,131.25	null	39	asian	46.796875	85	0.021	0.004999	28	0	0	yes	0.05	0.000125	dnr after sadm	5	77	0.099991	144	36	38.89844	45	2.399902	5	1.399902	147	7.30957	null	null	null	null	2	<2 mo. follow-up	2	7	1
30.10799	male	0	10	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	37	57,611	29,342.3906	null	30.5	asian	22.398438	21	0.823975	0.764893	4	0	0	no	null	null	no dnr	10	92	8.798828	112	27	37.59375	225	null	null	0.399963	134	7.459961	null	null	null	null	null	null	2.846191	2,013	0
50.37097	male	0	105	Cirrhosis	COPD/CHF/Cirrhosis	2	16	$11-$25k	0	465,380	304,749.25	null	22.25	white	21.296875	18	0.80896	0.690918	2	0	0	no	null	null	no dnr	105	98	8.398438	82	20	37.39844	197.5	3	6.799805	0.699951	138	7.319336	null	null	null	3	1	SIP>=30	1	2,013	0
74.48297	male	0	15	CHF	COPD/CHF/Cirrhosis	2	16	>$50k	0	18,134	12,751.7344	null	7.666664	white	16.296875	27	0.872925	0.787964	1	0	0	no	0.95	0.6	no dnr	15	111	6.899414	60	32	36.79688	null	3.799805	0.599976	1.599854	142	null	null	null	null	0	1	null	1	2,012	0
55.73199	male	0	13	Cirrhosis	COPD/CHF/Cirrhosis	2	8	under $11k	0	52,092	28,262.7031	null	17	hispanic	31	25	0.602905	0.41394	1	0	0	no	0.9	0.9	no dnr	13	121	19.699219	118	18	37.39844	404.75	2.199707	0.899902	0.799927	117	7.379883	null	null	null	7	6	SIP>=30	6	2,012	0
77.21295	female	0	7	COPD	COPD/CHF/Cirrhosis	2	0	null	0	9,078	6,898.4922	null	12	hispanic	21.796875	39	0.773926	0.638916	1	0	0	no	0.75	0.75	dnr after sadm	2	113	8.298828	93	25	36.19531	250	null	null	2.099609	145	7.269531	null	null	null	null	7	<2 mo. follow-up	7	51	1
61.02399	female	1	20	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	37	109,627	57,442.7812	null	30.333328	white	26	49	0.67395	0.577881	1	0	0	no	0.6	0.6	dnr after sadm	17	80	15.398438	128	30	38.5	217.5	2.299805	0.399963	2.399902	143	7.329102	null	null	null	null	null	<2 mo. follow-up	2.825195	20	1
56.48999	female	0	5	CHF	COPD/CHF/Cirrhosis	1	12	null	0	38,548	20,959.2031	null	16	hispanic	37.398438	53	0.546997	0.348999	4	0	0	no	null	null	no dnr	5	38	null	92	20	36	null	null	null	6	133	null	null	null	null	null	null	null	3.098145	113	1
57.53299	female	0	28	Cirrhosis	COPD/CHF/Cirrhosis	1	14	under $11k	0	156,556	103,090.438	null	14.5	hispanic	26.597656	37	0.688965	0.522949	1	0	0	no	0.7	0.5	no dnr	28	77	12.199219	92	18	37.59375	552.375	2.5	23.597656	0.899902	132	7.439453	null	null	null	null	null	no(M2 and SIP pres)	3.131836	2,010	0
68.98596	female	0	4	COPD	COPD/CHF/Cirrhosis	1	10	under $11k	0	5,763	2,965.9512	null	3	white	12.798828	21	0.910889	0.849976	1	0	0	no	0.99	0.95	no dnr	4	76	null	78	26	36.59375	280.9375	4	null	0.799927	142	7.359375	null	null	null	1	0	SIP>=30	0	603	1
41.97897	male	0	6	CHF	COPD/CHF/Cirrhosis	1	14	$11-$25k	0	5,552	3,679.8398	null	12	white	19.5	37	0.917969	0.860962	1	0	0	no	null	null	no dnr	6	120	8.398438	86	22	37.5	295.1875	null	null	1.799805	129	7.5	null	null	null	0	0	no(M2 and SIP pres)	0	518	1
19.79199	male	0	33	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	167,971	null	null	21.25	black	18.699219	5	0.932983	0.908936	4	0	0	no	0.9	0.75	no dnr	33	83	9.599609	52	6	39	310	null	null	null	131	7.439453	null	null	null	null	0	adl>=4 (>=5 if sur)	0	2,008	0
57.50897	female	0	4	CHF	COPD/CHF/Cirrhosis	0	14	under $11k	0	6,403	3,672.0723	null	11	black	23.199219	27	0.849976	0.75293	1	0	0	no	1	1	no dnr	4	83	14.298828	106	24	36.79688	280.9375	null	null	2.299805	138	7.449219	null	null	null	5	6	SIP>=30	6	841	1
73.40698	male	0	9	Colon Cancer	Cancer	1	null	null	0	22,934	14,292.2656	null	12.5	white	11.599609	23	0.866943	0.701904	1	0	0	metastatic	0.9	0.4	no dnr	9	71	16.5	76	10	37	null	4	0.599976	0.799927	141	null	null	null	null	null	null	null	2.467773	2,007	0
68.31799	male	0	6	Colon Cancer	Cancer	1	21	>$50k	0	9,205	5,793.1914	null	11	white	14.898438	8	0.838989	0.645996	1	0	0	metastatic	null	null	no dnr	6	89	10.599609	92	18	39	null	null	0.5	1	136	null	null	null	null	0	0	no(M2 and SIP pres)	0	172	1
75.79498	female	1	23	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	271,250	136,387.875	null	42.333313	white	40	76	0.283997	0.174988	8	0	0	no	null	null	dnr after sadm	21	59	30.597656	90	22	37.5	70.90625	1.899902	5.399414	2.699707	128	7.329102	null	null	null	null	null	<2 mo. follow-up	2.685547	23	1
45.71899	male	0	20	CHF	COPD/CHF/Cirrhosis	1	12	null	0	115,112	61,771.0625	null	25.666656	white	21.796875	30	0.893921	0.821899	1	0	0	no	0.9	0.5	no dnr	20	57	12.298828	96	22	36	185	3.899902	null	1.399902	135	7.599609	null	null	null	0	0	no(M2 and SIP pres)	0	2,006	0
75.48798	male	0	36	CHF	COPD/CHF/Cirrhosis	1	16	under $11k	0	120,920	64,202.375	null	23.25	hispanic	32.296875	39	0.601929	0.412964	1	0	0	no	0.5	0.5	dnr after sadm	16	62	21.796875	102	24	36.59375	415	null	null	4	124	7.429688	null	null	null	2	0	null	0	79	1
74.995	female	1	25	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	348,931	173,763.5	null	43	white	35.695313	53	0.41095	0.290955	10	0	0	no	null	null	dnr after sadm	23	50	51.195313	120	18	36.19531	237.5	2.899902	1	4.799805	135	7.439453	null	null	null	null	null	<2 mo. follow-up	2.442383	25	1
56.19397	male	1	21	ARF/MOSF w/Sepsis	ARF/MOSF	0	6	null	26	230,733	119,196	null	41.333313	other	36.695313	70	0.362	0.243988	15	0	0	no	null	null	dnr after sadm	20	68	26.699219	130	28	38.5	121.65625	1.699951	3.899902	2.099609	131	7.449219	null	null	null	null	3	<2 mo. follow-up	3	21	1
44.849	female	0	12	MOSF w/Malig	ARF/MOSF	2	10	$11-$25k	0	25,176	12,210.7812	null	19.5	hispanic	24.796875	32	0.709961	0.620972	1	0	0	yes	0.6	0.4	no dnr	12	91	4.699219	70	32	37.09375	447.5625	2.299805	7	0.799927	136	7.359375	null	null	null	0	0	no(M2 and SIP pres)	0	229	1
51.09698	female	0	19	CHF	COPD/CHF/Cirrhosis	1	11	null	0	30,877	17,287.9531	null	12	black	22.296875	43	0.876953	0.794922	1	0	0	no	0.95	0.95	no dnr	19	100	5.699219	120	32	37.59375	203.6875	4.199219	0.199982	4	140	7.459961	null	null	null	2	null	null	1.839	489	1
36.30899	male	0	11	CHF	COPD/CHF/Cirrhosis	2	16	null	0	23,476	14,620.8047	null	15.5	white	26.097656	31	0.878906	0.797974	1	0	0	no	0.6	0.5	no dnr	11	64	6.799805	115	20	36.29688	null	4.399414	4.5	1.299805	121	null	null	null	null	1	0	null	0	653	1
76.25696	male	0	9	CHF	COPD/CHF/Cirrhosis	3	12	null	0	14,926	8,138.4414	null	7.5	white	17.796875	32	0.852905	0.757935	1	0	0	no	0.9	0.75	no dnr	9	74	9.298828	96	30	36.39844	266.625	null	1.099854	1.199951	141	7.399414	null	null	null	1	2	null	2	2,001	0
51.30499	male	0	25	CHF	COPD/CHF/Cirrhosis	1	12	under $11k	0	52,187	30,876.375	null	11.75	black	26.097656	33	0.822998	0.711914	2	0	0	no	0.8	0.75	no dnr	25	71	null	104	18	36.5	null	null	null	2.399902	128	null	null	null	null	1	0	no(M2 and SIP pres)	0	162	1
74.54297	female	0	7	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	9,631	5,835.1602	null	8	white	22	23	0.78894	0.660889	1	0	0	no	null	null	no dnr	7	83	14.199219	92	22	36.39844	164	3.299805	0.299988	0.799927	137	7.449219	null	null	null	0	0	no(M2 and SIP pres)	0	2,000	0
54.30798	male	0	12	Lung Cancer	Cancer	1	17	$25-$50k	0	29,939	17,625.75	null	14.5	white	20.898438	8	0.650879	0.345947	1	0	0	metastatic	1	1	no dnr	12	95	11.599609	108	22	38	183	null	null	0.799927	136	7.399414	null	null	null	0	0	no(M2 and SIP pres)	0	536	1
77.57697	female	0	3	CHF	COPD/CHF/Cirrhosis	2	null	null	0	3,124	2,022.1035	null	6	other	17.296875	27	0.853882	0.758911	1	1	0	no	null	null	no dnr	3	90	12.398438	84	32	36.59375	276.1875	null	null	0.799927	139	7.469727	null	null	null	null	null	null	2.308594	244	1
84.95795	male	0	17	CHF	COPD/CHF/Cirrhosis	4	14	>$50k	0	30,942	18,401.7188	null	8.666664	white	14.099609	21	0.865967	0.777954	1	0	0	no	0.95	0.85	no dnr	17	92	13.699219	80	32	37.19531	313.3125	3.799805	0.299988	1.299805	137	7.429688	null	null	null	0	null	no(M2 and SIP pres)	0.4948	1,998	0
41.52197	male	1	21	MOSF w/Malig	ARF/MOSF	2	18	>$50k	26	320,843	165,178.875	null	32.666657	white	36.09375	78	0.171997	0.08699	26	0	0	yes	0.1	0.001	no dnr	21	66	0.199982	130	18	37.5	315	1.899902	3.799805	7.299805	134	7.359375	null	null	null	null	0	<2 mo. follow-up	0	21	1
39.685	female	0	35	ARF/MOSF w/Sepsis	ARF/MOSF	0	22	$25-$50k	0	220,639	109,700.75	null	33	white	26	56	0.820923	0.759888	7	1	0	no	0.6	0.6	no dnr	35	62	36.695313	125	24	39.19531	208.5625	1.599854	0.399963	7.699219	139	7.399414	null	null	null	null	0	no(M2 and SIP pres)	0	1,995	0
72.55896	female	1	4	COPD	COPD/CHF/Cirrhosis	3	null	null	0	4,894	3,078.6016	null	6	white	26	25	0.60791	0.419983	1	0	0	metastatic	null	null	dnr after sadm	1	123	13.298828	98	32	37.19531	144.875	null	null	0.5	136	7.339844	null	null	null	null	null	<2 mo. follow-up	3.955078	4	1
60.10098	male	0	15	Cirrhosis	COPD/CHF/Cirrhosis	1	null	null	0	63,466	32,079.9531	null	27.666656	white	22.597656	40	0.746948	0.601929	1	0	0	no	null	null	no dnr	15	110	6.299805	125	10	38.09375	208	2.799805	3.399902	1	142	7.439453	null	null	null	null	null	null	2.381348	195	1
70.81195	male	0	8	CHF	COPD/CHF/Cirrhosis	1	null	null	0	6,254	4,126.0742	null	5	black	16.199219	20	0.882935	0.804932	1	0	0	no	0.9	0.8	no dnr	8	88	6.899414	80	22	37	null	null	null	1.799805	142	null	null	null	null	null	null	null	2.595703	1,992	0
30.76199	male	0	6	CHF	COPD/CHF/Cirrhosis	1	10	under $11k	0	8,437	5,632.8516	null	10	hispanic	24.5	37	0.903931	0.838989	1	0	0	no	0.8	0.7	no dnr	6	70	6.599609	122	16	36.5	528.5	null	null	2.099609	133	7.459961	null	null	null	0	null	no(M2 and SIP pres)	0.4948	1,990	0
64.23798	male	0	61	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	321,716	162,087.25	null	34.5	white	26	32	0.738892	0.657959	5	0	0	no	0.9	0.9	no dnr	61	68	9.5	122	12	38.69531	114	null	null	1.299805	136	7.319336	null	null	null	null	0	null	0	974	1
51.70999	male	0	12	CHF	COPD/CHF/Cirrhosis	1	null	null	0	31,222	18,348.2188	null	16	asian	18.796875	21	0.903931	0.838989	1	0	0	no	0.8	0.2	no dnr	12	50	6.699219	75	20	36.79688	null	3.699707	null	0.899902	138	null	null	null	null	0	0	no(M2 and SIP pres)	0	1,987	0
64.64294	male	0	17	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	null	9	180,786	95,272.6875	null	25.333328	white	30.898438	49	0.554932	0.441956	17	1	0	no	null	null	no dnr	17	68	13.298828	92	38	38.79688	113.67188	3.399902	1.099854	2.299805	133	7.479492	null	null	null	null	0	no(M2 and SIP pres)	0	254	1
69.41498	male	0	6	Lung Cancer	Cancer	2	16	$25-$50k	26	8,706	5,389.1289	null	8	white	25.5	11	0.352966	0.075989	1	0	1	metastatic	null	null	dnr after sadm	2	109	5.299805	68	20	36.89844	null	2.699707	null	0.699951	133	null	null	null	null	null	2	adl>=4 (>=5 if sur)	2	101	1
57.19098	male	0	9	CHF	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	28,476	17,331.0938	null	18	white	24.398438	42	0.836914	0.73291	1	0	0	no	0.3	0.1	no dnr	9	59	16	85	26	36.79688	204.75	null	0.5	0.799927	126	7.449219	null	null	null	0	null	<2 mo. follow-up	0.4948	42	1
37.73297	male	0	9	CHF	COPD/CHF/Cirrhosis	1	12	$25-$50k	0	26,278	14,961.0938	null	19	white	24.199219	23	0.891968	0.81897	1	0	0	no	0.2	0.05	no dnr	9	67	7.5	130	16	36.5	347.5625	3	0.599976	0.899902	132	7.469727	null	null	null	5	7	<2 mo. follow-up	7	20	1
44.05499	female	0	7	Colon Cancer	Cancer	0	16	>$50k	0	18,563	11,069.4688	null	8	white	12.898438	5	0.890991	0.751953	1	0	0	metastatic	1	0.7	no dnr	7	85	8.5	72	20	37.39844	null	null	null	null	140	null	null	null	null	0	0	no(M2 and SIP pres)	0	293	1
72.15594	male	0	35	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	>$50k	26	187,014	95,392.75	null	27.25	white	24.699219	29	0.61792	0.512939	7	0	0	no	0.8	0.8	no dnr	35	75	17.296875	120	24	38.29688	257.5	2.599609	4.899414	0.699951	135	7.5	null	null	null	null	null	adl>=4 (>=5 if sur)	2.70459	1,984	0
45.56598	male	1	5	MOSF w/Malig	ARF/MOSF	3	18	$25-$50k	0	181,701	92,664.625	null	51	white	69.296875	133	0	0	39	0	0	yes	null	null	dnr after sadm	3	33	0.299988	140	33	38.5	129	2.299805	31.398438	4.799805	142	7.359375	null	null	null	null	0	<2 mo. follow-up	0	5	1
41.95999	male	0	4	Lung Cancer	Cancer	1	16	>$50k	0	4,173	2,648.0977	null	3	white	13.398438	7	0.813965	0.600952	1	0	0	metastatic	0.95	0.8	no dnr	4	97	10.798828	88	20	36.39844	380.9375	3.799805	0.5	1.099854	133	7.479492	null	null	null	null	null	no(M2 and SIP pres)	2.179688	503	1
59.31	male	0	72	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	>$50k	26	538,692	301,788.5	null	32.5	white	37.796875	71	0.311951	0.198975	13	0	0	no	0.5	0.4	no dnr	72	60	19.398438	160	38	37.29688	113.32812	3.099609	13.099609	1.299805	142	7.509766	null	null	null	null	2	adl>=4 (>=5 if sur)	2	1,981	0
45.61499	female	1	44	Cirrhosis	COPD/CHF/Cirrhosis	3	16	>$50k	44	302,353	155,929.75	null	30.5	white	27.199219	55	0.5979	0.406982	1	0	0	no	0.3	0.25	dnr after sadm	41	57	13.599609	112	28	38.59375	134.4375	1.699951	1.5	0.899902	139	7.179688	null	null	null	null	null	<2 mo. follow-up	3.54541	44	1
65.98499	female	0	10	Colon Cancer	Cancer	1	12	null	0	18,980	9,559.2266	null	13.5	hispanic	11.099609	19	0.880981	0.730957	1	1	0	metastatic	null	null	no dnr	10	127	17.796875	96	26	38.89844	372	4.099609	0.299988	0.799927	140	7.399414	null	null	null	1	null	no(M2 and SIP pres)	1.1669	540	1
95.79199	female	1	19	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	44	74,764	36,613.2812	null	29	white	19.199219	18	0.610962	0.504883	1	0	1	no	null	null	dnr after sadm	16	88	11.599609	65	8	37.19531	360	2.599609	null	1.699951	147	7.419922	null	null	null	null	null	<2 mo. follow-up	5.941406	19	1
76.59094	male	0	8	Colon Cancer	Cancer	1	17	$11-$25k	0	7,137	4,350.3672	null	4.5	white	7.799805	6	0.896973	0.762939	1	0	0	metastatic	null	null	dnr after sadm	1	83	12.798828	76	18	38.29688	390.4375	4.099609	0.799927	0.799927	146	7.439453	null	null	null	1	2	null	2	142	1
68.10095	male	0	4	CHF	COPD/CHF/Cirrhosis	1	12	$11-$25k	0	9,586	5,151.0469	null	7	white	17.898438	33	0.873901	0.790894	1	0	0	no	0.9	0.7	no dnr	4	72	5.899414	80	18	36.79688	null	null	null	2.199707	137	null	null	null	null	null	null	no(M2 and SIP pres)	1.971924	1,979	0
78.85297	female	1	6	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	37	39,420	20,195.5781	null	27	white	21.5	30	0.642944	0.541992	3	0	1	no	null	null	dnr after sadm	4	60	36.195313	112	11	36.59375	214.28125	null	1.099854	1.099854	137	7.419922	null	null	null	null	null	<2 mo. follow-up	4.947266	6	1
37.87	male	0	120	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	9	397,017	207,528.5	null	31	white	31.097656	48	0.703979	0.61499	14	0	0	no	0.1	0.001	no dnr	120	83	23.5	122	26	37.59375	257.5	null	3.099609	5.199219	134	7.379883	null	null	null	null	null	null	2.540039	1,977	0
74.90997	female	0	6	COPD	COPD/CHF/Cirrhosis	1	16	null	0	8,166	4,166.6992	null	8	white	15.599609	9	0.866943	0.779907	1	0	0	no	0.8	0.7	no dnr	6	106	11.398438	84	22	37	424	null	null	0.799927	142	7.399414	null	null	null	0	0	<2 mo. follow-up	0	18	1
31.702	female	0	49	Cirrhosis	COPD/CHF/Cirrhosis	0	14	null	0	231,119	101,867.938	null	15.5	black	20.097656	24	0.903931	0.837891	1	0	0	no	0.2	0.1	no dnr	49	77	7.699219	80	20	37.19531	490.4375	2.199707	2.699707	1.399902	127	7.489258	null	null	null	6	1	SIP>=30	1	1,973	0
54.93997	female	0	10	CHF	COPD/CHF/Cirrhosis	3	14	$11-$25k	0	27,561	15,429.6172	null	21	white	20.199219	22	0.885986	0.80896	1	0	0	no	null	null	no dnr	10	55	6.199219	104	24	36.79688	504	3.599609	1.099854	0.799927	136	7.459961	null	null	null	1	0	<2 mo. follow-up	0	55	1
43.30197	male	1	39	Cirrhosis	COPD/CHF/Cirrhosis	3	14	under $11k	0	283,145	108,597.562	null	13.75	hispanic	23.597656	33	0.826904	0.716919	1	0	0	no	null	null	no dnr	39	83	10	80	20	37	null	2.099609	13	1	130	null	null	null	null	3	2	<2 mo. follow-up	2	39	1
54.92999	female	0	8	Lung Cancer	Cancer	0	12	$25-$50k	0	15,392	7,098.3008	null	10	asian	22	25	0.625977	0.312988	1	0	0	metastatic	null	null	no dnr	8	143	10.699219	84	40	36.19531	null	3.299805	null	0.799927	135	null	null	null	null	1	0	<2 mo. follow-up	0	50	1
70.21497	male	0	7	Colon Cancer	Cancer	1	12	$11-$25k	0	8,442	5,144.7188	null	11.5	white	25.398438	27	0.653931	0.348999	1	1	0	metastatic	0.9	0.5	no dnr	7	117	10.199219	22	18	38	null	3.099609	0.699951	1.299805	137	null	null	null	null	0	0	no(M2 and SIP pres)	0	173	1
67.09399	female	0	27	Cirrhosis	COPD/CHF/Cirrhosis	2	3	under $11k	0	71,992	37,093.125	null	17.5	black	23.199219	28	0.68689	0.518921	1	0	0	no	null	null	dnr after sadm	5	104	21.796875	82	20	37	null	2	6.599609	0.599976	135	null	null	null	null	null	1	null	1	1,969	0
65.05096	male	0	10	Cirrhosis	COPD/CHF/Cirrhosis	2	14	$25-$50k	0	14,944	9,489.5391	null	9	white	27.796875	36	0.5979	0.407959	1	0	0	no	null	null	no dnr	10	77	12.099609	72	22	36.39844	null	2.5	21.699219	1.199951	130	null	null	null	null	0	2	null	2	125	1
69.34698	male	1	42	MOSF w/Malig	ARF/MOSF	2	18	null	0	433,684	214,329.25	null	38.25	asian	25.398438	27	0.492981	0.375	11	1	0	metastatic	null	null	no dnr	42	112	10.398438	125	14	36.5	274.25	3.799805	5.699219	1.099854	140	7.449219	null	null	null	null	4	<2 mo. follow-up	4	42	1
64.98798	female	0	4	Lung Cancer	Cancer	0	null	null	0	8,137	4,735.9922	null	9	white	18.296875	11	0.680908	0.385986	1	0	0	metastatic	null	null	no dnr	4	110	18.796875	80	20	36.39844	null	null	null	0.699951	134	null	null	null	null	null	null	<2 mo. follow-up	2.198731	33	1
80.62097	male	1	4	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	37	104,163	53,111.3125	null	38	white	35.898438	77	0.167999	0.084991	14	0	0	no	null	null	dnr after sadm	2	61	23	140	32	39.19531	75.54688	2.299805	1.5	1.899902	135	7.129883	null	null	null	null	null	<2 mo. follow-up	3.361816	4	1
72.172	male	1	12	Lung Cancer	Cancer	1	null	null	0	62,158	31,507.8125	null	25	white	34.195313	47	0.222992	0.023998	1	0	0	metastatic	0.5	0.25	no dnr	12	63	5.099609	140	36	36.5	176.65625	2.699707	null	1.099854	135	7.55957	null	null	null	null	0	<2 mo. follow-up	0	12	1
53.06198	male	0	3	COPD	COPD/CHF/Cirrhosis	2	null	under $11k	0	6,734	3,384.6172	null	4	white	19.296875	28	0.890991	0.817993	1	0	0	yes	null	null	dnr after sadm	1	77	10.898438	72	24	36.39844	280.9375	3.899902	null	0.799927	126	7.479492	null	null	null	null	null	<2 mo. follow-up	2.619141	28	1
52.50699	female	1	6	CHF	COPD/CHF/Cirrhosis	1	12	$11-$25k	0	20,735	11,022.1016	null	9	white	20.898438	24	0.884888	0.80896	1	1	0	no	0.6	0.2	dnr after sadm	6	67	8.5	88	20	36.59375	null	3.099609	0.699951	1.399902	129	null	null	null	null	6	7	<2 mo. follow-up	7	6	1
74.97095	male	0	19	Colon Cancer	Cancer	0	null	null	0	43,009	22,430.0625	null	12.333328	white	3.299805	26	0.928955	0.832886	1	0	0	metastatic	0.9	0.85	no dnr	19	91	6.799805	88	20	36.79688	null	4.599609	2.5	1.099854	142	null	null	null	null	null	null	null	1.91626	259	1
53.34998	male	0	52	ARF/MOSF w/Sepsis	ARF/MOSF	0	17	>$50k	26	483,991	285,715.25	null	39	asian	40.5	71	0.286987	0.176971	9	0	0	no	0.5	0.2	no dnr	52	73	19.5	158	36	39.29688	187.5	3.599609	11.099609	2.699707	154	7.369141	null	null	null	null	6	null	6	126	1
89.58795	male	1	4	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	100	19,238	9,710.9062	null	34	white	54.898438	80	0	0	1	0	0	metastatic	null	null	no dnr	4	33	13.699219	0	0	38.5	122	2.299805	0.5	1	130	7.289062	null	null	null	null	null	<2 mo. follow-up	5.568359	4	1
56.62399	male	0	11	Colon Cancer	Cancer	0	12	>$50k	0	27,408	15,270.6484	null	12	white	5.699219	12	0.928955	0.833984	1	0	0	metastatic	null	null	no dnr	11	116	8.199219	102	18	38.39844	null	4.299805	0.299988	1.199951	136	null	null	null	null	0	0	no(M2 and SIP pres)	0	559	1
75.04199	male	0	6	Colon Cancer	Cancer	0	16	null	0	8,723	5,835.2305	null	16	hispanic	35.898438	47	0.35199	0.074997	1	0	0	metastatic	null	null	no dnr	6	123	16.296875	112	28	36	352.375	2.899902	1.699951	7.599609	134	7.479492	null	null	null	null	null	SIP>=30	2.249512	123	1
75.76196	male	0	21	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	74,162	40,581	null	23.666656	white	22.699219	28	0.734985	0.652954	8	0	0	no	0.8	0.8	no dnr	21	68	16.597656	79	20	37.19531	132.71875	null	null	1.099854	132	7.489258	null	null	null	0	null	null	0.4948	1,962	0

End of preview. Expand in Data Studio

Dataset Card for "support2"

More Information needed

Downloads last month: 43

Size of downloaded dataset files:

Size of the auto-converted Parquet files:

Number of rows: